Spending is up and mortality is down
The healthcare industry takes a lot of well-earned flack for cost, inefficiency, difficulty of use...I could go on, but I won't, because that industry also pays my mortgage.

The healthcare industry takes a lot of well-earned flack for cost, inefficiency, difficulty of use…I could go on, but I won’t, because that industry also pays my mortgage. But here is one unambiguous, unalloyed win deserving of celebration: cancer mortality rates have declined by 33% since peaking in 1991, averting the deaths of more than 4 million people—thanks both to a successful stop-smoking campaign started a generation before the 1991 peak, plus massive advances in treatment over the past several decades. It is an achievement nothing short of stupendous, a monument to human drive and ingenuity, and a rare opportunity for me to write effusively and without hyperbole.
Union Healthcare Insight
Log in to continue reading
Not a member yet? Create a free account for limited access.
Related insights
Can AI help close a persistent gap in cardiovascular care?
What’s next for GLP-1 innovation: A primer on the race reshaping pharma and chronic disease care
Specialty value-based care: The next phase of VBC